From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. STDs

STDs

The latest information on sexually transmitted diseases — summaries and comments on Chlamydia, gonorrhea, herpes, HIV, HPV, syphilis, and more — drawn from across our primary care and specialty care areas. Sign up now for monthly e-mail alerts on new content.

SUMMARY AND COMMENT

Can HPV Vaccination Combat Genital Warts?

Yes — and the benefit extends beyond vaccinated women to their male sexual partners.

SUMMARY AND COMMENT

Therapeutic HPV Vaccination for Preventing Progression of Vulvar Intraepithelial NeoplasiaFree

Clinical responses were achieved in women with grade 3 VIN who were vaccinated against HPV-16 viral oncoproteins.

SUMMARY AND COMMENT

Darunavir + Raltegravir + Etravirine = High Rate of Treatment Success

Ninety percent of highly treatment-experienced patients who received this combination achieved virologic suppression at week 24; results were sustained at week 48.

SUMMARY AND COMMENT

Life Expectancy for HIV-Infected Patients in the U.S.

Average life expectancy continues to improve, but disparities persist.

SUMMARY AND COMMENT

A Glimmer of Hope for HIV VaccinesFree

A large trial has shown that a vaccine can protect against HIV acquisition. The task now is to figure out how to build on this initial success.

SUMMARY AND COMMENT

Ethnicity Affects Attitudes About HPV Vaccination

Ethnic minority women in the U.K. were less likely than white women to know about HPV and to view vaccination as acceptable.

SUMMARY AND COMMENT

STI and HIV Services Fall Short for Sexually Active Young Women

More than one third of young women who receive contraceptive services are not concurrently offered STI or HIV services.

SUMMARY AND COMMENT

First HIV Integrase Inhibitor Performs Well in Previously Untreated Patients

Raltegravir and efavirenz yielded similar rates of virologic suppression, but raltegravir had fewer side effects.

NEWS IN CONTEXT

HIV Vaccine Study Shows PromiseFree

A new vaccine regimen, tested among more than 16,000 young adults, was found to offer modest protection against HIV acquisition.

SUMMARY AND COMMENT

Testing for and Prevalence of HCV Infection in HIV-Infected Patients

During a 12-year observational study among HIV-infected patients, the prevalence of HCV coinfection decreased from 37% to 20%.

Read more STDs articles >>

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?

Medical NewsRSS

November 6, 2009

Daily Medical News Alert

A Journal Watch E-mail Alert

Browse arrow

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.